Please Pay Attention To The Scenario Zero Plagiarism 5 Refer

Please Pay Attention To The Scenariozero Plagirism5 Referencesnotepat

Please Pay Attention To The Scenario zero Plagiarism 5 References notepat.

Please Pay Attention To The Scenario zero Plagiarism 5 References notepat.

PLEASE PAY ATTENTION TO THE SCENARIO ZERO PLAGIARISM 5 REFERENCES Note: Patient is 65 years old African American female, alert and oriented x2 with confusion. Resident has a diagnosis of paranoid schizophrenia and dementia. Patient is on Risperdal 4 mg once at bedtime and Haldol 10 mg every 6 hours PRN for agitation. Patient was seen by psychiatrist on 01/25/2020, and no medication reduction was recommended. Patient remains stable at this time.

Patient will be seen again in three months. Develop diagnoses for clients receiving psychotherapy. Analyze legal and ethical implications of counseling clients with psychiatric disorders.

The assignment related to this learning objective is introduced this week. Select a client whom you observed or counseled this week. Then, address the following in your practicum journal: Describe the client (without violating HIPAA regulations) and identify any pertinent history or medical information, including prescribed medications. Using the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5), explain and justify your diagnosis for this client. Explain any legal and/or ethical implications related to counseling this client. Support your approach with evidence-based literature.

Paper For Above instruction

The case of a 65-year-old African American female patient presenting with paranoid schizophrenia and dementia, maintained on Risperdal and PRN Haldol, highlights critical aspects of diagnosing and ethically managing psychiatric clients. This paper discusses the potential diagnoses, legal and ethical considerations, and evidence-based approaches pertinent to counseling such complex cases, emphasizing responsible practice within clinical psychology.

Client Description and Medical Background

The client is an elderly woman with a history of paranoid schizophrenia, a chronic psychotic disorder characterized by delusions and hallucinations, and dementia, potentially contributing to cognitive decline and confusion. She is alert and oriented to person and place but exhibits confusion, which underscores the complexity of her neurological status. Her medication regimen includes Risperdal (risperidone) 4 mg at bedtime, an atypical antipsychotic targeting psychosis symptoms, and PRN Haldol (haloperidol) 10 mg every six hours for agitation—a typical antipsychotic used for acute agitation in psychiatric settings.

Notably, her psychiatrist last evaluated her on January 25, 2020, with no recommended change in medication, suggesting stability despite her neurocognitive challenges. Her ongoing treatment aims to balance her psychotic symptoms with minimizing adverse effects, especially considering her age-related vulnerabilities.

Diagnosis Justification Using DSM-5 Criteria

According to DSM-5 guidelines, her primary diagnosis likely incorporates conditions from the Schizophrenia Spectrum and Other Psychotic Disorders and neurocognitive disorders. The main considerations are:

- Paranoid Schizophrenia (DSM-5 295.30): Characterized by persistent delusions and hallucinations without significant cognitive impairment or disorganized speech (American Psychiatric Association, 2013). Her history of paranoia and ongoing psychosis align with this diagnosis, especially if her delusions are prominent.

- Major Neurocognitive Disorder (Dementia) (DSM-5 294.02): Evidenced by cognitive decline affecting independence, likely exacerbated by her age and clinical presentation. Confirmation would require comprehensive assessment, including cognitive testing, but her confusion and history suggest this diagnosis as a comorbid condition.

Given her age, multiple diagnoses intersect, and the most fitting DSM-5 diagnosis is "Schizophrenia, paranoid type" with a "mild neurocognitive disorder due to Alzheimer's disease" (if confirmed through further assessments). Her medication regime supports her schizophrenia diagnosis, and her cognitive status warrants concurrent management of dementia symptoms.

Legal and Ethical Considerations in Counseling

Counseling clients with co-occurring psychiatric and neurocognitive disorders raises unique legal and ethical vulnerabilities. Among these, maintaining confidentiality, informed consent, and competence stand paramount.

- Confidentiality: Clinicians must uphold HIPAA regulations while being cautious about disclosures, especially if cognitive deficits impair her ability to give informed consent. In cases of diminished capacity, involving family or legal representatives for decision-making is ethically warranted (Appelbaum & Grisso, 2001).

- Informed consent: Given her confusion, assessing her capacity to consent to counseling or therapeutic interventions is critical. In situations where capacity is impaired, obtaining consent from surrogate decision-makers or legal guardians aligns with ethical standards.

- Risk management: The use of PRN medications such as Haldol for agitation must be monitored to prevent misuse or adverse effects, especially in elderly patients susceptible to medication side effects like EPS or tardive dyskinesia.

- Competence: Counselors must be proficient in managing dual diagnoses, understanding pharmacological effects, and recognizing the limits of their practice regarding neurocognitive disorders, following the guidelines of the American Counseling Association (ACA, 2014).

Ethically, clinicians should prioritize beneficence and nonmaleficence, ensuring interventions do not harm and are designed with the client’s best interest. They must also adhere to standards of cultural competence, recognizing the unique challenges faced by African American elderly women, including potential disparities in healthcare (Snowden, 2012).

Supporting Evidence-Based Practice

Research underscores the importance of integrated treatment approaches combining pharmacotherapy with psychotherapy tailored for older adults with psychosis and dementia. Psychoeducation, cognitive-behavioral strategies, and caregiver support are vital components. For instance, a systematic review by Vahia et al. (2018) advocates for person-centered approaches that respect cultural considerations and aim to improve quality of life. Clinicians should also remain vigilant about side effects of medications like risperidone and haloperidol, adjusting treatments as necessary and collaborating closely with psychiatrists (Kales et al., 2012).

Conclusion

Effective counseling of elderly clients with schizophrenia and dementia requires accurate diagnosis, sensitive handling of legal and ethical issues, and evidence-based practices. Recognizing the interplay between psychiatric symptoms and cognitive decline, while respecting client autonomy and cultural nuances, forms the cornerstone of ethical mental health care. Continuous professional learning, interdisciplinary collaboration, and cultural competence remain essential for ethically sound and effective treatment outcomes.

References

  • American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.
  • Appelbaum, P. S., & Grisso, T. (2001). MacArthur Treatment Competence Study. The Law Journal, 1(1), 104–112.
  • Kales, H. C., Blow, F. C., & Mankowski, E. (2012). Pharmacological management of depression and anxiety in older adults with dementia: An evidence-based review. Journal of Clinical Psychiatry, 73(8), e1102–e1111.
  • Snowden, L. R. (2012). Health and mental health policies' role in better understanding and closing racial health disparities. The American Psychologist, 67(7), 524–531.
  • Vahia, I. V., Myznikov, O., & Jeste, D. V. (2018). Psychotherapeutic Interventions for Late-Life Psychosis. Psychiatric Clinics, 41(3), 481–491.
  • Kupfer, D. J., & Robinson, R. G. (2020). Pharmacotherapy for Psychosis in Older Adults. Neuropsychopharmacology, 45(10), 1859–1868.
  • American Counseling Association. (2014). ACA Code of Ethics. Alexandria, VA: Author.
  • Vahia, I. V., Lachman, M. E., & Reynolds, C. A. (2021). Aging and mental health: A lifespan perspective. Behavioral Sciences & the Law, 39(1), 4–29.
  • Ballard, C., Corbett, A., Aarsland, D., & Travis, S. (2018). Psychosis in Alzheimer's Disease. International Psychogeriatrics, 30(1), 19–34.
  • Hickling, E. J., & Williams, W. (2011). Cultural competence and mental health disparities among African Americans. Community Mental Health Journal, 47, 673–679.

Related Assignments